Litcius/Paper detail

Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination

Crystal M. North, Amy K. Barczak, Robert H. Goldstein, Brian C. Healy, Dianne M. Finkelstein, Delaney D Ding, Andy Kim, Julie Boucau, Bennett Shaw, Rebecca F. Gilbert, Tammy D. Vyas, Zahra Reynolds, Katherine J. Siddle, Bronwyn MacInnis, James Regan, James P. Flynn, Manish C. Choudhary, Jatin M. Vyas, Karl Laskowski, Anand S. Dighe, Jacob E. Lemieux, Jonathan Z. Li, Lindsey R. Baden, Mark J. Siedner, Ann E. Woolley, Chana A. Sacks

2021Clinical Infectious Diseases33 citationsDOIOpen Access PDF

Abstract

The impact of coronavirus disease 2019 vaccination on viral characteristics of breakthrough infections is unknown. In this prospective cohort study, incidence of severe acute respiratory syndrome coronavirus 2 infection decreased following vaccination. Although asymptomatic positive tests were observed following vaccination, the higher cycle thresholds, repeat negative tests, and inability to culture virus raise questions about their clinical significance.

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Asymptomatic2019-20 coronavirus outbreakIncidence (geometry)VaccinationProspective cohort studyBetacoronavirusCohort studyCohortVirologyInternal medicineOutbreakDiseaseInfectious disease (medical specialty)PhysicsOpticsSARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studiesVaccine Coverage and Hesitancy